Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (7)
Blood Cancer Journal (6)
Nature Communications (3)
European Journal of Human Genetics (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (9)
Correspondence (4)
Amendments and Corrections (2)
Reviews (2)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Genetics
Health care
Medical research
Pathogenesis
Risk factors
Signs and symptoms

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–17 of 17 results

Advanced filters: Author: Annette Juul-Vangsted Clear advanced filters

Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk

Laura Duran-Lozano
Gudmar Thorleifsson
Björn Nilsson
Amendments and CorrectionsOpen Access16 Nov 2021
Blood Cancer Journal

Volume: 11, P: 1
Correction: Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

Elad Ziv
Eric Dean
Celine Vachon
Amendments and Corrections09 Dec 2015
Nature Communications

Volume: 6, P: 1
Deciphering the genetics and mechanisms of predisposition to multiple myeloma

Multiple myeloma (MM) is an incurable blood malignancy. Here, the authors report 35 MM risk loci and two causal mechanisms for genetic MM risk: longer telomeres and elevated plasma B-cell maturation antigen (BCMA) and interleukin−5 receptor alpha (IL5RA) levels.

Molly Went
Laura Duran-Lozano
Björn Nilsson
ResearchOpen Access05 Aug 2024
Nature Communications

Volume: 15, P: 1-15
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

Multiple myeloma is an incurable blood cancer with family history being a strong contributing risk factor. Here Ziv et al.perform a genome-wide association study for genetic variation associated with myeloma survival, identifying FOPNL variants associated with worse clinical outcomes.

Elad Ziv
Eric Dean
Celine Vachon
Research22 Jul 2015
Nature Communications

Volume: 6, P: 1-9
Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014

Sissel Helm-Petersen
Rasmus Sørrig
Annette J. Vangsted
Research22 Feb 2018
Leukemia

Volume: 32, P: 2054-2057
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease

Thomas Lund
Michael Tveden Gundesen
Fredrik Schjesvold
CorrespondenceOpen Access15 Apr 2024
Blood Cancer Journal

Volume: 14, P: 1-5
Germline variants at SOHLH2 influence multiple myeloma risk

Laura Duran-Lozano
Gudmar Thorleifsson
Björn Nilsson
ResearchOpen Access19 Apr 2021
Blood Cancer Journal

Volume: 11, P: 1-8
The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

Tobias W. Klausen
Henrik Gregersen
Annette J. Vangsted
Research28 Sept 2018
Leukemia

Volume: 33, P: 546-549
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation

Jakob Nordberg Nørgaard
Niels Abildgaard
Fredrik Schjesvold
Research11 Aug 2023
Leukemia

Volume: 37, P: 2107-2114
A polygenic risk score for multiple myeloma risk prediction

Federico Canzian
Chiara Piredda
Daniele Campa
ResearchOpen Access30 Nov 2021
European Journal of Human Genetics

Volume: 30, P: 474-479
Genetically determined telomere length and multiple myeloma risk and outcome

Matteo Giaccherini
Angelica Macauda
Daniele Campa
ResearchOpen Access14 Apr 2021
Blood Cancer Journal

Volume: 11, P: 1-10
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio

Agoston Gyula Szabo
Tobias Wirenfeldt Klausen
Annette Juul Vangsted
CorrespondenceOpen Access07 Apr 2021
Blood Cancer Journal

Volume: 11, P: 1-4
Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

S W Erickson
O W Stephens
A J Vangsted
Correspondence26 Aug 2015
Leukemia

Volume: 29, P: 2418-2421
Potential value of pre-planned imaging of bone disease in multiple myeloma

Michael T. Gundesen
Jon Thor Asmussen
Thomas Lund
CorrespondenceOpen Access07 Jul 2023
Blood Cancer Journal

Volume: 13, P: 1-5
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

Maroulio Pertesi
Maxime Vallée
Charles Dumontet
ResearchOpen Access09 Apr 2019
Leukemia

Volume: 33, P: 2324-2330
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

Evangelos Terpos
Pellegrino Musto
Heinz Ludwig
Reviews04 May 2023
Leukemia

Volume: 37, P: 1175-1185
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

Evangelos Terpos
Monika Engelhardt
Pieter Sonneveld
Reviews22 May 2020
Leukemia

Volume: 34, P: 2000-2011